← All stocks

BMY vs SNY

Bristol-Myers Squibb Company Common Stock vs Sanofi ADS. Side-by-side ACCE scores, valuation, profitability, and growth.

BMY
Bristol-Myers Squibb Company Common Stock
Healthcare
62.62
127.91B
SNY
Sanofi ADS
Healthcare
42.50
101.79B
ACCE scores
BMY
SNY
Composite score
Out of 100
78
59
Growth
64
40
Value
88
80
Quality
83
75
Momentum
77
40
Valuation
BMY
SNY
Price
62.62
42.50
Market cap
127.91B
101.79B
Trailing P/E
13.79
22.96
Forward P/E
9.65
8.58
EV / EBITDA
9.68
12.84
Dividend yield
4.0%
9.6%
Profitability
BMY
SNY
ROE
46.6%
5.7%
Net margin
18.9%
8.1%
Debt / equity
2.44
0.26
Free cash flow
12.85B
10.14B
Growth
BMY
SNY
Revenue growth (YoY)
5.7%
14.6%
Earnings growth (YoY)
1.5%
-91.2%
Analyst target
66.71
53.72
See full analysis